(1)
NURHIDAYAH, M.; FADILAH, F.; ARSIANTI, A.; BAHTIAR, A. IDENTIFICATION OF FGFR INHIBITOR AS ST2 RECEPTOR/INTERLEUKIN-1 RECEPTOR-LIKE 1 INHIBITOR IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DUE TO EXPOSURE TO E-CIGARETTES BY NETWORK PHARMACOLOGY AND MOLECULAR DOCKING PREDICTION. Int J App Pharm 2022, 14, 256-266.